See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Natural Disasters
Stock Markets
Social Media
Tariffs
UK Economy
Taxes
Soccer
Donald Trump
Education
Senate
Artificial Intelligence
Published • loading... • Updated

Monoclonal Antibody Can Reverse Effects of Bleeding and Complications Linked to Common Medication for Heart Attacks

Summary by Newswise
Trial led by Mount Sinai researcher could save lives for patients in need of urgent surgery, invasive procedures, or experiencing major bleeding
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All
Left
Center
Right
DataemiaDataemia

Bentracimab reverses ticagrelor’s antiplatelet effects during surgery and bleeding events

Summarize this content to 100 words A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor’s antiplatelet effects in patients undergoing urgent surgery or experiencing major bleeding, according to a study presented at the American College of Cardiology’s Annual Scientific Session (ACC.25). The antidote, bentracimab, rapidly restored normal platelet function in ticagrelor-treated patients.…

Read Full Article
Cardiovascular NewsCardiovascular News

ACC.25: Bentracimab can reverse bleeding complications linked to ticagrelor - Cardiovascular News

Deepak L Bhatt. Photo by © ACC/Phil McCarten 2025 An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat patients with acute coronary syndromes, prior heart attack, stroke, and coronary artery disease. Those are the findings from a multicentre international clinical trial analysing bentracimab, the first experim…

Read Full Article
NewswiseNewswise

Monoclonal Antibody Can Reverse Effects of Bleeding and Complications Linked to Common Medication for Heart Attacks

Trial led by Mount Sinai researcher could save lives for patients in need of urgent surgery, invasive procedures, or experiencing major bleeding

·Charlottesville, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Newswise broke the news in Charlottesville, United States on Saturday, March 29, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal